Peritoneal Cavity

  • 3E0M0 - Open
    • 3E0M05
      • 3E0M05Z - Introduction Peritoneal Cavity to No Qualifier with Adhesion Barrier, Open Approach
  • 3E0M3 - Percutaneous
    • 3E0M30
      • 3E0M304 - Introduction Peritoneal Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
      • 3E0M305 - Introduction Peritoneal Cavity to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0M30M - Introduction Peritoneal Cavity to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
      • 3E0M30Y - Introduction Peritoneal Cavity to Hyperthermic with Antineoplastic, Percutaneous Approach
    • 3E0M32
      • 3E0M328 - Introduction Peritoneal Cavity to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E0M329 - Introduction Peritoneal Cavity to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0M33
      • 3E0M33Z - Introduction Peritoneal Cavity to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0M35
      • 3E0M35Z - Introduction Peritoneal Cavity to No Qualifier with Adhesion Barrier, Percutaneous Approach
    • 3E0M36
      • 3E0M36Z - Introduction Peritoneal Cavity to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0M37
      • 3E0M37Z - Introduction Peritoneal Cavity to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E0M3B
      • 3E0M3BZ - Introduction Peritoneal Cavity to No Qualifier with Anesthetic Agent, Percutaneous Approach
    • 3E0M3G
      • 3E0M3GC - Introduction Peritoneal Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Approach
    • 3E0M3H
      • 3E0M3HZ - Introduction Peritoneal Cavity to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E0M3K
      • 3E0M3KZ - Introduction Peritoneal Cavity to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E0M3N
      • 3E0M3NZ - Introduction Peritoneal Cavity to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E0M3S
      • 3E0M3SF - Introduction Peritoneal Cavity to Other Gas with Gas, Percutaneous Approach
    • 3E0M3T
      • 3E0M3TZ - Introduction Peritoneal Cavity to No Qualifier with Destructive Agent, Percutaneous Approach
  • 3E0M4 - Percutaneous Endoscopic
    • 3E0M45
      • 3E0M45Z - Introduction Peritoneal Cavity to No Qualifier with Adhesion Barrier, Percutaneous Endoscopic Approach
    • 3E0M4G
      • 3E0M4GC - Introduction Peritoneal Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach
  • 3E0M7 - Via Natural or Artificial Opening
    • 3E0M70
      • 3E0M704 - Introduction Peritoneal Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0M705 - Introduction Peritoneal Cavity to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0M70M - Introduction Peritoneal Cavity to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach
    • 3E0M7S
      • 3E0M7SF - Introduction Peritoneal Cavity to Other Gas with Gas, Via Natural or Artificial Opening Approach